Andy Tompkins, MD, MHS
Working Title
Professor of Psychiatry
Preferred Pronouns
He/Him/His
- MHS, 08/2014 - Clinical Investigation, Johns Hopkins Bloomberg School of Public Health
- Post-doctoral Fellowship, 06/2010 - Behavioral Pharmacology / Addictions, Johns Hopkins University School of Medicine
- Residency, 06/2008 - Psychiatry, Johns Hopkins Hospital
- Internship, 06/2005 - Psychiatry-Medicine, Johns Hopkins Bayview Medical Center
- MD, 05/2004 - Medicine, New York Medical College
- BS, 05/1999 - Biology / English, Emory University
Meditation
Narcotic Antagonists
Opioid-Related Disorders
Vital Signs
Hyperalgesia
Substance Withdrawal Syndrome
Pain Threshold
Chronic Pain
Analgesics, Opioid
Naltrexone
Buprenorphine
Hydromorphone
Yoga
Opiate Substitution Treatment
Morphine
April 3, 2018 - NPR Forum Interview
September 29, 2021 - September 29, 2026 - Project JUNO Community (JUstice-iNvolved Opioid use disorder treatment engagement in Community) , Executive Director / PI . Sponsor: SAMHSA, Sponsor Award ID: H79TI084269
September 30, 2002 - February 28, 2025 - Western States Node of the National Drug Abuse Treatment Clinical Trials Network , Site PI . Sponsor: NIH, Sponsor Award ID: UG1DA015815
September 30, 2018 - September 29, 2021 - Project HOUDINI LINK: Hospital Opioid Use Disorder treatment Initiation and LINKage to care , Executive Director / PI . Sponsor: SAMHSA, Sponsor Award ID: H79TI081419-01
September 30, 2019 - August 31, 2021 - The Effect of Chronic Pain on Delay Discounting in Methadone Patients , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21DA047520
August 1, 2016 - June 30, 2021 - Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01DA040644
May 15, 2017 - April 30, 2020 - Opioid and cannabinoid combinations in laboratory and clinical pain , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01DA042751
July 1, 2018 - June 30, 2019 - Improving the Opioid Treatment Outpatient Program (OTOP) through the Addition of Yoga Therapy , Principal Investigator . Sponsor: San Francisco General Hospital Foundation, Sponsor Award ID: 34843
June 1, 2012 - August 31, 2018 - Mechanisms of Sleep Disruption Hyperalgesia , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01DA032922
July 1, 2012 - June 30, 2017 - Role of Sleep in the Treatment of Cannabis Dependence , Co-Investigator . Sponsor: NIH, Sponsor Award ID: U01DA031784
July 1, 2012 - May 31, 2017 - Optimizing Pain Treatment while Reducing Abuse Liability in Opioid Dependence , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K23DA029609
September 15, 2008 - January 31, 2013 - Multisite Controlled Trial of Cocaine Vaccine (3 of 6) Baltimore Treatment Site , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01DA025251
September 20, 2006 - July 31, 2012 - Clinical Trial of Topiramate for Cocaine Addiction , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01DA021808
February 1, 1981 - June 30, 2011 - Human Behavioral Pharmacology of Substance Abuse , Post-doctoral Fellow . Sponsor: NIH, Sponsor Award ID: 5T32DA007209-27
February 1, 1981 - June 30, 2011 - Human Behavioral Pharmacology of Substance Abuse , Post-doctoral Fellow . Sponsor: NIH, Sponsor Award ID: 2T32DA007209-26
Contact information
995 Potrero Avenue, #511
San Francisco, CA 94110
United States